Cargando…
Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma
Immunotherapy has good potential to eradicate tumors in the long term. However, due to the low immunogenicity of tumor cells, current cancer immunotherapies are not effective. To address this limitation, we constructed a BSA-FA functionalized iron-containing metal-organic framework (TPL@TFBF) that t...
Autores principales: | Wang, Shengmei, Guo, Qiuyan, Xu, Rubing, Lin, Peng, Deng, Guoyan, Xia, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585872/ https://www.ncbi.nlm.nih.gov/pubmed/37858186 http://dx.doi.org/10.1186/s12951-023-02146-0 |
Ejemplares similares
-
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
por: Gao, Weitong, et al.
Publicado: (2022) -
Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
por: Zhang, Liang, et al.
Publicado: (2023) -
Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin
por: Wu, Xia, et al.
Publicado: (2022) -
Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response
por: De Backer, Joey, et al.
Publicado: (2022) -
Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
por: Yu, Jie, et al.
Publicado: (2021)